Chronic recurrent multifocal osteomyelitis: diagnosis and treatment
- PMID: 33278106
- DOI: 10.1097/MOP.0000000000000970
Chronic recurrent multifocal osteomyelitis: diagnosis and treatment
Abstract
Purpose of review: The aim of this article is to review recent findings regarding the diagnosis and treatment of chronic recurrent multifocal osteomyelitis (CRMO).
Recent findings: An adequate understanding of pathophysiology along with the new advances in MRI imaging make it possible to determine the extent of disease and establish early treatment. TNF-α inhibitors and bisphosphonates have shown to be a well-tolerated and efficient treatment for CRMO providing both symptomatic relief and normalization of bone morphology.
Summary: The results of recent studies suggest that a better knowledge of the genetic and molecular factors will allow early diagnosis and the development of more effective individualized treatments in the future.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Hedrich CM, Morbach H, Reiser C, Girschick HJ. New insights into adult and paediatric chronic nonbacterial osteomyelitis (CNO). Curr Rheumatol Rep 2020; 22:52Published 2020 Jul 23. doi:10.1007/s11926-020-00928-1. - DOI
-
- Zhao Y, Ferguson PJ. Chronic nonbacterial osteomyelitis and autoinflammatory bone diseases. Clin Immunol 2020; 216:108458doi:10.1016/j.clim.2020.108458. - DOI
-
- Cassidy JT, Petty RE. Textbook of pediatric rheumatology. Philadelphia, PA: Elsevier Saunders; 2005.
-
- Labro MT. Macrolide antibiotics: current and future uses. Expert Opin Pharmacother 2004; 5:541–550.
-
- Lukens JR, Gross JM, Calabrese C, et al. Critical role for inflammasome-independent IL-1β production in osteomyelitis. Proc Natl Acad Sci USA 2014; 111:1066–1071.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Research Materials
